文献速递外周动脉疾病

腋-双股与腋-单股动脉旁路移植术的围手术期结局与通畅率相似

Axillary-bifemoral and axillary-unifemoral artery grafts have similar perioperative outcomes and patency.
PubMed 文献 · J Vasc Surg · 2019-08-05

基于血管质量倡议(VQI)数据库2010-2017年多中心数据,比较腋-单股(AxUF)与腋-双股(AxBF)旁路移植术的围手术期及远期结局。

要点

  • AxUF与AxBF旁路移植术的围手术期并发症和死亡率相似。
  • 1年通畅率、无大不良肢体事件生存率及生存率两组无显著差异。
  • AxUF组无大截肢生存率较低,但多因素分析显示移植构型非独立预测因素。

核心结论

  • AxUF与AxBF旁路移植术的围手术期结局和1年结局相似。
  • 1年移植血管通畅率在AxBF与AxUF之间无显著差异。
  • 接受这类重建的患者合并症多,长期生存率低。

研究设计与样本

  • 回顾性多中心队列研究,查询Vascular Quality Initiative数据库2010-2017年数据。
  • 纳入因间歇性跛行、静息痛和组织缺损行AxUF或AxBF旁路移植术的患者,排除急性肢体缺血。
  • 共识别412例(32.9%)AxUF和839例(67.1%)AxBF移植。

主要发现

  • AxUF组更常用于急诊病例,患者更年轻、男性、不能行走、糖尿病,且术前抗凝、严重肢体缺血、既往旁路、动脉瘤修复、外周血管介入和大截肢比例更高(P < .05)。
  • 围手术期伤口并发症(4.2% vs 2.9%;P = .23)、心脏并发症(7.3% vs 10.4%;P = .08)、肺部并发症(4.1% vs 6%;P = .18)、早期狭窄/闭塞(0.2% vs 0.8%;P = .22)、围手术期死亡率(2.9% vs 3.2%;P = .77)和住院时间(6.4 ± 5.6天 vs 6.7 ± 8天;P = .29)无显著差异。
  • AxUF组平均估计失血量(268.1 mL vs 348.6 mL;P < .001)和平均手术时间(201分钟 vs 224.1分钟;P < .001)显著更低。
  • Kaplan-Meier分析显示1年无移植血管闭塞率(62.6% vs 71.8%;P = .074)、无大不良肢体事件生存率(57.1% vs 66.6%;P = .052)和生存率(86% vs 86%;P = .897)无显著差异,但AxUF组无大截肢生存率较低(63.7% vs 73%;P = .028)。
  • 多因素分析显示移植构型未独立预测闭塞/死亡(HR 1.06;95%CI 0.77-1.46;P = .72)、截肢/死亡(HR 1.12;95%CI 0.83-1.51;P = .45)、大不良肢体事件/死亡(HR 0.97;95%CI 0.73-1.3;P = .85)或死亡(HR 0.91;95%CI 0.65-1.26;P = .55)。

临床怎么用

  • 对于需要腋-股动脉旁路移植的患者,AxUF和AxBF在围手术期结局和1年通畅率方面相似。
  • AxUF手术时间更短、失血量更少,但无大截肢生存率较低,需结合患者具体情况选择术式。
  • 接受此类手术的患者合并症多、长期生存率低,应注重围手术期管理和长期随访。

局限性

  • 回顾性数据库研究,可能存在选择偏倚和未测量混杂因素。
  • 仅纳入VQI数据库,结果可能无法推广至其他人群。
  • 随访时间有限,仅报告1年和3年部分结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: It has been suggested that more bypass outflow targets for bypass grafts improve patency and outcomes. Our objective was to examine this in a multicenter contemporary series of axillary to femoral artery grafts. METHODS: The Vascular Quality Initiative database was queried for all axillary-unifemoral (AxUF) and axillary-bifemoral (AxBF) bypass grafts performed between 2010 and 2017 for claudication, rest pain, and tissue loss. Patients with acute limb ischemia were excluded. Patients' demographics and comorbidities as well as operative details and outcomes were recorded. Univariable, multivariable, and Kaplan-Meier analyses were used to assess long-term outcomes. RESULTS: There were 412 (32.9%) AxUF grafts and 839 (67.1%) AxBF grafts identified. Overall, the mean age of the patients was 68.3 years, 51.1% were male, and 84.7% were white. Compared with AxBF grafts, AxUF grafts were more often performed for urgent cases; in patients who were younger, male, nonambulatory, and diabetic; and in those with preoperative anticoagulation, critical limb ischemia, prior bypass, aneurysm repair, peripheral vascular intervention, and major amputation (P < .05 for all). There were no significant differences between AxUF and AxBF grafts in perioperative wound complications (4.2% vs 2.9%; P = .23), cardiac complications (7.3% vs 10.4%; P = .08), pulmonary complications (4.1% vs 6%, P = .18), early stenosis/occlusion (0.2% vs 0.8%; P = .22), perioperative mortality (2.9% vs 3.2%; P = .77), and length of stay (6.4 ± 5.6 days vs 6.7 ± 8 days; P = .29). The mean estimated blood loss (268.1 mL vs 348.6 mL; P < .001) and mean operative time (201 minutes vs 224.1 minutes; P < .001) were significantly lower for AxUF grafts. Kaplan-Meier analysis showed that AxUF and AxBF grafts had similar freedom from graft occlusion (62.6% vs 71.8%; P = .074), major adverse limb event-free survival (57.1% vs 66.6%; P = .052), and survival (86% vs 86%; P = .897) at 1 year. Major amputation-free survival was lower for AxUF grafts (63.7% vs 73%; P = .028). Multivariable analysis also showed that the type of graft configuration did not independently predict occlusion/death (hazard ratio [HR], 1.06; 95% confidence interval [CI], 0.77-1.46; P = .72), amputation/death (HR, 1.12; 95% CI, 0.83-1.51; P = .45), major adverse limb event/death (HR, 0.97; 95% CI, 0.73-1.3; P = .85), or mortality (HR, 0.91; 95% CI, 0.65-1.26; P = .55). Three-year survival after placement of AxUF and AxBF grafts was similar (75.1% vs 78.2%; P = .414). CONCLUSIONS: AxUF and AxBF grafts have similar perioperative and 1-year outcomes. Graft patency was not significantly different between an AxBF graft and an AxUF graft at 1 year. Overall, patients treated with these reconstructions have many comorbidities and low long-term survival.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Hardouin S, Cheng TW, Farber A, et al. Axillary-bifemoral and axillary-unifemoral artery grafts have similar perioperative outcomes and patency. J Vasc Surg. 2019. PMID: 31395294. doi:10.1016/j.jvs.2019.05.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。